LEP and type 2 diabetes mellitus: Exacerbated circulatory proinflammatory (TNF-α and leptin), and decreased anti-inflammatory (adiponectin) adipokine levels in individuals with central obesity and the clustering of other 4 MetS risk factors might be associated with the risk of T2D